Home > Research > Publications & Outputs > Genomic Dissection of Bipolar Disorder and Schi...

Electronic data

  • 28

    Accepted author manuscript, 16.5 MB, multipart/x-zip

    Available under license: CC BY-NC-ND

  • BDSCZ2-final

    Rights statement: This is the author’s version of a work that was accepted for publication in Cell. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Cell, 173, 7, 2018 DOI: 10.1016/j.cell.2018.05.046

    Accepted author manuscript, 738 KB, PDF document

    Available under license: CC BY-NC-ND

Links

Text available via DOI:

View graph of relations

Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. / Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium.

In: Cell, Vol. 173, No. 7, 14.06.2018, p. 1705-1715.e16.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium 2018, 'Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes', Cell, vol. 173, no. 7, pp. 1705-1715.e16. https://doi.org/10.1016/j.cell.2018.05.046

APA

Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium (2018). Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell, 173(7), 1705-1715.e16. https://doi.org/10.1016/j.cell.2018.05.046

Vancouver

Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell. 2018 Jun 14;173(7):1705-1715.e16. https://doi.org/10.1016/j.cell.2018.05.046

Author

Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. / Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. In: Cell. 2018 ; Vol. 173, No. 7. pp. 1705-1715.e16.

Bibtex

@article{b7df94c44f394c50aa180af3174ae396,
title = "Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes",
abstract = "Schizophrenia and bipolar disorder are two distinct diagnoses that share symptomology. Understanding the genetic factors contributing to the shared and disorder-specific symptoms will be crucial for improving diagnosis and treatment. In genetic data consisting of 53,555 cases (20,129 bipolar disorder [BD], 33,426 schizophrenia [SCZ]) and 54,065 controls, we identified 114 genome-wide significant loci implicating synaptic and neuronal pathways shared between disorders. Comparing SCZ to BD (23,585 SCZ, 15,270 BD) identified four genomic regions including one with disorder-independent causal variants and potassium ion response genes as contributing to differences in biology between the disorders. Polygenic risk score (PRS) analyses identified several significant correlations within case-only phenotypes including SCZ PRS with psychotic features and age of onset in BD. For the first time, we discover specific loci that distinguish between BD and SCZ and identify polygenic components underlying multiple symptom dimensions. These results point to the utility of genetics to inform symptomology and potential treatment.",
author = "{Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium} and Jo Knight",
note = "This is the author{\textquoteright}s version of a work that was accepted for publication in Cell. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Cell, 173, 7, 2018 DOI: 10.1016/j.cell.2018.05.046",
year = "2018",
month = jun,
day = "14",
doi = "10.1016/j.cell.2018.05.046",
language = "English",
volume = "173",
pages = "1705--1715.e16",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "7",

}

RIS

TY - JOUR

T1 - Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes

AU - Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium

AU - Knight, Jo

N1 - This is the author’s version of a work that was accepted for publication in Cell. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Cell, 173, 7, 2018 DOI: 10.1016/j.cell.2018.05.046

PY - 2018/6/14

Y1 - 2018/6/14

N2 - Schizophrenia and bipolar disorder are two distinct diagnoses that share symptomology. Understanding the genetic factors contributing to the shared and disorder-specific symptoms will be crucial for improving diagnosis and treatment. In genetic data consisting of 53,555 cases (20,129 bipolar disorder [BD], 33,426 schizophrenia [SCZ]) and 54,065 controls, we identified 114 genome-wide significant loci implicating synaptic and neuronal pathways shared between disorders. Comparing SCZ to BD (23,585 SCZ, 15,270 BD) identified four genomic regions including one with disorder-independent causal variants and potassium ion response genes as contributing to differences in biology between the disorders. Polygenic risk score (PRS) analyses identified several significant correlations within case-only phenotypes including SCZ PRS with psychotic features and age of onset in BD. For the first time, we discover specific loci that distinguish between BD and SCZ and identify polygenic components underlying multiple symptom dimensions. These results point to the utility of genetics to inform symptomology and potential treatment.

AB - Schizophrenia and bipolar disorder are two distinct diagnoses that share symptomology. Understanding the genetic factors contributing to the shared and disorder-specific symptoms will be crucial for improving diagnosis and treatment. In genetic data consisting of 53,555 cases (20,129 bipolar disorder [BD], 33,426 schizophrenia [SCZ]) and 54,065 controls, we identified 114 genome-wide significant loci implicating synaptic and neuronal pathways shared between disorders. Comparing SCZ to BD (23,585 SCZ, 15,270 BD) identified four genomic regions including one with disorder-independent causal variants and potassium ion response genes as contributing to differences in biology between the disorders. Polygenic risk score (PRS) analyses identified several significant correlations within case-only phenotypes including SCZ PRS with psychotic features and age of onset in BD. For the first time, we discover specific loci that distinguish between BD and SCZ and identify polygenic components underlying multiple symptom dimensions. These results point to the utility of genetics to inform symptomology and potential treatment.

U2 - 10.1016/j.cell.2018.05.046

DO - 10.1016/j.cell.2018.05.046

M3 - Journal article

C2 - 29906448

VL - 173

SP - 1705-1715.e16

JO - Cell

JF - Cell

SN - 0092-8674

IS - 7

ER -